Pancreatic Cancer Research

ResearcherKitasato UniversityNo recent work listed

Yukio Suzuki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2178-6562; OpenAlex author ID A5004673673. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 3

  1. Mechanisms of metformin's anti‑tumor activity against gemcitabine‑resistant pancreatic adenocarcinoma. Co-author DOI 10.3892/ijo.2018.4662↗
  2. Acquired resistance to gemcitabine and cross-resistance in human pancreatic cancer clones. Last author DOI 10.1097/cad.0000000000000165↗
  3. Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines. Co-author DOI 10.1097/cad.0b013e328350e8c7↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuko Kitagawa · 1 shared paper, 2019 · strength 0.14
  2. Keiichi Suzuki · 1 shared paper, 2019 · strength 0.14
  3. Yoshinori Yamada · 2 shared papers, 2012–2015 · strength 0.09
  4. Hiroshi Yoneyama C · 2 shared papers, 2012–2015 · strength 0.09
  5. Yoshihito Morimoto · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.